- Visibility 386 Views
- Downloads 652 Downloads
- Permissions
- DOI 10.18231/j.ijcaap.2025.015
-
CrossMark
Quantification of the analgesic effect of Ximenia americana bark extracts and involvement of opioid receptors
- Author Details:
-
Yacouba Adebo Adehouni *
-
Amara Kamagate
-
Paul Maomy
-
Sylvain Landry Kouakou
-
Généviève Irie-N’guessan
-
N'doua Gisele Kouakou-Siransy
Yacouba Adebo Adehouni *
Background: Pain is a common symptom requiring timely treatment. This study aimed to quantify the analgesic potential of a decoctate (DXA) and a hydroethanol extract (EHEXA) of Ximenia americana, and also to assess the role of opioid receptors.
Materials and Methods: Analgesic effects were measured using Writhing and formaldehyde tests, and the mechanism was investigated by blocking opioid receptors. Efficacy (Emax) and potency (ED??) were the main evaluted pharmacodynamic parameters.
Results: In writhing test, both extracts reduced dose-dependently abdominal contortions for up to 90 minutes, with Emax values of 100%. ED?? ranged from 2.84 -1.60 mg/kg (DXA), 7.94 - 0.6 mg/kg (EHEXA), 19.05 - 16.50 mg/kg (paracetamol), and 2.81-3.16 mg/kg (tramadol).
In formaldehyde test, both extracts reduced again dose-dependently neurogenic and inflammatory pain. Emax values were 42% and 55% for neurogenic pain, and 65% and 82% for inflammatory pain (DXA and EHEXA, respectively). Potency (ED??) values were around 6 - 7.5 mg/kg of Ximenia americana.
Administration of naloxone (Opioid receptor antagonist) inhibited the analgesic effect of the extracts, with a reduction of 23 to 74% for DXA and 42 to 84% for EHEXA from 30 minutes to 90 minutes after, indicating opioid receptor involvement.
Conclusion: Ximenia americana extracts showed analgesic effects comparable to reference drugs (paracetamol, tramadol, ketoprofen) and may act as partial opioid receptor agonists at doses ?10 mg/kg, supporting their potential use in managing mild to moderate pain.
Keywords: Analgesics, Pharmacodynamic parameters, Mechanisms of action, Ximenia americana
References
- International Association for the Study of Pain. IASP Terminology: Pain. 2024.
- Chambers CT, Dola J, Tutelman PR, Langley CL, Parker JA, Cormier BT, et al. The prevalence of chronic pain in children and adolescents: A systematic review update and meta-analysis. Pain. 2024;165(10):2215–34.
- Soro TY, Traore F, Sakande J. Activité analgésique de l'extrait aqueux de Ximenia americana (Linné) (Olacaceae). Comptes Rendus Biologies. 2009;332(4):371–7.
- World Health Organization. WHO traditional medicine strategy 2014-2023. Geneva: WHO; 2013 [cited 2024 Jun 20].
- Organisation Ouest-Africaine de la Santé. Pharmacopée d'Afrique de l'Ouest. 1 st ed. Knust-Junction; 2013.
- Adehouni YA, Maomy P, Kamagate A, Effo KE, Kouakou SL, Djadji ATL. Evaluation of the Analgesic and Anti-Inflammatory Activity of the Decoction and Hydroethanolic Extract of Ximenia americana L. (Olacaceae) Bark. Pharmacol Pharm. 2025;16(4):105–23.
- Soro TY, Zahoui OS, Nene-Bi AS, Traore F. Analgesic activity of the fractions of the aqueous extract of Ximenia americana (Linné) (Olacaceae). Int J Pharmacol Toxicol. 2016;4(1):1–6.
- Nyangacha R, Mwangi J, Mworia J. Antinociceptive effect of Pentas lanceolata and Ximenia americana medicinal plants used to treat malaria traditionally in Kenya. Afr J Pharmacol Ther. 2016;5(2):87–92.
- Konaté K, Kiessoun B, Nacoulma OG. Anti-Nociceptive and Anti- Inflammatory Properties of Polyphenol-Rich Fractions of Roots from Ximenia americana L., (Olacaceae), in Experimental Mice. Int J Pharmacol Phytochem Res. 2018;12(1):281–97.
- Kenmogne SB, Ngassoum M, Tchatchueng JB, Vardamides JC, Dongmo A. Extraction assistée par micro-ondes de composés analgésiques de la racine de Ximenia americana (Olacaceae). Rev Rech Sci Chim. 2014;2231:606
- Pessoa RT, da Silva LYS, Alcântara IS, Silva TM, da Silva ES, da Costa RHS, et al. Antinociceptive potential of Ximenia americana L. bark extract and caffeic acid: Insights into pain modulation pathways. Pharmaceuticals. 2024;17(12):1671.
- Organisation for Economic Co-operation and Development. OECD guidelines for the testing of chemicals: Good laboratory practice [Internet]. [cited 2025 0 1 04]. Paris; 2018
- Boolamou B, Lapo A, Camara K, Assane M, Bassene E, Samb A. Activité anti-inflammatoire du décocté aqueux des écorces de racines de Morinda geminata DC (Rubiaceae). Int J Biol Chem Sci. 2015;8:1871–5.
- Seo J, Lee S, Elam ML, Johnson SA, Kang J, Arjmandi BH. Study to find the best extraction solvent for use with guava leaves (Psidium 112 Adehouni et al. / IP International Journal of Comprehensive and Advanced Pharmacology 2025;10(2):104–112 guajava L.) for high antioxidant efficacy. Food Sci Nutr. 2014;2(2):174–80.
- Ali-Rachedi F, Meraghni S, Touaibia N, Marniche S. Analyse quantitative des composés phénoliques d'une endémique algérienne Scabiosa atropurpurea sub. Maritima L. Bull Soc R Sci Liège. 2018;87:13–21.
- Togola S, Konaré MA, Diakité M, Diarra N, Tounkara F, Sanogo R, et al. Evaluation of the content of total alkaloids at different stages of development of Datura innoxia Mill, a plant used in traditional medicine in Mali. Am J Innov Res Appl Sci. 2023;16(4):112–20.
- Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109–10.
- Dubuisson D, Dennis SG. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977;4(2):161–74.
- Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: An evaluation of the method. Pain. 1992;51(1):5–17.
- Mahdian Dehkordi FM, Kaboutari J, Zendehdel M, Javdani M. The antinociceptive effect of artemisinin on the inflammatory pain and role of GABAergic and opioidergic systems. Korean J Pain. 2019;32(3):160–7.
- De Sousa DP. Medicinal essential oils: Chemical, pharmacological and therapeutic aspects. New York: Nova Science Publishers; 2012.
- Hijazi MA, El-Mallah A, Aboul-Ela M, Ellakany A. Evaluation of analgesic activity of Papaver libanoticum extract in mice: Involvement of opioids receptors. Evid Based Complement Alternat Med. 2017;2017:8935085.
- D'Amato ME, Baumgartner MR, Haas C, Coble MD. Ethical publication of research on genetics and genomics of biological material: Guidelines and recommendations. Forensic Sci Int Rep. 2020;2:100091.
- Cohen R, Tauzin M, Rybak A, Ouldali N, Grimprel E. Définitions et implications des paramètres pharmacocinétiques - pharmacodynamiques des antibiotiques en pratique clinique pédiatrique. J Pediatr Pueric. 2024;37(3):123–8.
- Kenakin T. Pharmacology in drug discovery and development: Understanding drug response. 2nd ed. Amsterdam: Elsevier; 2017.
- Beaulieu P, Pichette V, Desroches J, du Souich P, editors. Précis de pharmacologie: Du fondamental à la clinique. Montréal: Presses de l’Université de Montréal; 2015.
- Le Bars D, Pollin B, Plaghki L. Quelle est la validité conceptuelle des tests et modèles animaux de douleurs? Douleur Analg. 2012;25(1):2–30.
- Matricon J, Gelot A, Ardid D. Modèles expérimentaux de douleurs pelvi-périnéales. Douleur Analg. 2007;20(3):173–9.
- Beirith A, Ferreira J, Santos ARS, Calixto JB. Mechanisms underlying the antinociception caused by ethanolic extract obtained from the leaves of Melissa officinalis in mice. J Ethnopharmacol. 2002;83(1-2):109–13.
- Derry S, Wiffen PJ, Moore RA. Tramadol for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD012522.
- Högestätt ED, Jönsson BA, Ermund A, Andersson DA, Björk H, Alexander JP, et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase- dependent arachidonic acid conjugation in the nervous system. J Biol Chem. 2005;280(36):31405-12.
- Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987;30(1):103–
- Ntchapda F, Dimo T, Sonfack AS, Nkeng-Efouet PA, Théophile D. Anti-inflammatory and analgesic properties of aqueous bark extract of Ximenia americana L. (Olacaceae) in rodent models. BMC Complement Altern Med. 2015;15:258.
- Koné WM, Atindehou KK, Terreaux C, Hostettmann K, Traoré D, Dosso M. Traditional medicine in north Côte-d'Ivoire: screening of 50 medicinal plants for antibacterial activity. J Ethnopharmacol. 2004;93(1):43–9.
- Kerharo J, Adam JG. La pharmacopée sénégalaise traditionnelle. Paris: Vigot; 1974.
- Nacoulma/Ouédraogo, O.G. (1996) Plantes médicinales et Pratiques médicales Traditionnelles au Burkina Faso: Cas du plateau central T1 & T2. Thèse de l’université Ouaga I Pr Joseph KI-ZERBO, 91-
- Akoègninou A, van der Burg WJ, van der Maesen LJG. Flore analytique du Bénin. Leiden: Backhuys Publishers; 2006.
- Chhabra SC, Mahunnah RLA, Mshiu EN. Plants used in traditional medicine in Eastern Tanzania. J Ethnopharmacol. 1990;29(3):295–
- Van Wyk BE, Oudtshoorn B, Gericke N. Medicinal plants of South Africa. 2nd ed. Pretoria: Briza Publications; 2018.
- Diallo D, Hveem B, Mahmoud MA, Berge G, Paulsen BS, Maiga A. An ethnobotanical survey of herbal drugs of Gourma district, Mali. J Ethnopharmacol. 2002;79(1):43–7.
- Stein C. Opioid receptors. Annu Rev Med. 2016;67:433–51.
- Zöllner C, Stein C. Opioids. Handb Exp Pharmacol. 2007;177:31–
- Depiesse M. Représentations du mésusage d'antalgiques opioïdes. Thèse de doctorat en médecine, Université de Strasbourg. Strasbourg 2023.
- Gauthier M, Buxeraud J, Faure S. Les médicaments à risque d'usage détourné et de dépendance. Actual Pharm. 2024;63(635):20–6.
- Grim TW, Acevedo-Canabal A, Bohn LM, Navarro HA. Methods to quantify ligand efficacy at the mu-opioid receptor. Methods Mol Biol. 2020;2201:131–50.
- Mbikay M. Potentiel thérapeutique des feuilles de Moringa oleifera dans l'hyperglycémie chronique et la dyslipidémie: une revue. Front Pharmacol. 2012;3:24.